¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"persecutory type of paranoid disorder"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • multifactorial genetic disorder
    ´ÙÀÎÀÚÀ¯ÀüÁúȯ
  • multiple personality disorder
    ´ÙÁßÀΰÝÀå¾Ö
  • myelodysplastic disorder
    °ñ¼öÇü¼ºÀÌ»óÁúȯ, °ñ¼öÇü¼ºÀå¾Ö
  • myeloproliferative disorder
    °ñ¼öÁõ½ÄÁúȯ
  • myopathic disorder
    ±Ù(À°)º´Áõ
  • mendelian disorder
    ¸àµ¨À¯ÀüÁúȯ
  • menstrual disorder
    ¿ù°æÀå¾Ö
  • mental disorder
    Á¤½ÅÀå¾Ö
  • metabolic disorder
    ´ë»çÀå¾Ö
  • neuroleptic-induced disorder
    Ç×Á¤½Åº´¾à¹°À¯¹ßÀå¾Ö
  • neurological disorder
    ½Å°æ°èÀå¾Ö, ½Å°æ°èÁúȯ
  • neuromuscular disorder
    ½Å°æ±Ù(À°)Àå¾Ö, ½Å°æ±Ù(À°)Áúȯ
  • neurotic disorder
    ½Å°æÁõ¼ºÀå¾Ö
  • neurovascular disorder
    ½Å°æÇ÷°üÀå¾Ö
  • nutritional disorder
    ¿µ¾çÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • intermittent explosive disorder
    °£ÇæÆø¹ßÀå¾Ö, °£ÇæÆø¹ßº´
  • intestinal motility disorder
    âÀڿÀå¾Ö, Àå¿îµ¿Áúȯ
  • language disorder
    ¾ð¾îÀå¾Ö
  • learning disorder
    ÇнÀÀå¾Ö
  • lymphoproliferative disorder
    ¸²ÇÁ¼¼Æ÷Áõ½ÄÁúȯ
  • major affective disorder
    ÁÖ¿äÁ¤µ¿Àå¾Ö, ÁÖ¿äÁ¤µ¿º´
  • malabsorptive disorder
    Èí¼öÀå¾ÖÁúȯ
  • mendelian disorder
    ¸àµ¨À¯ÀüÁúȯ
  • menstrual disorder
    ¿ù°æÀå¾Ö
  • mental disorder
    Á¤½ÅÀå¾Ö, Á¤½Åº´
  • metabolic disorder
    ´ë»çÀå¾Ö
  • micturition disorder
    ¹è´¢Àå¾Ö
  • minor depressive disorder
    °æÁõ¿ì¿ïÀå¾Ö
  • mood disorder
    ±âºÐÀå¾Ö, ±âºÐº´
  • motor neuron disorder
    ¿îµ¿½Å°æ¼¼Æ÷Àå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • personality disorder, obsessional
    °­¹Ú¼º ÀΰÝÀå¾Ö
  • personality disorder, obsessive-compulsive
    °­¹Ú¼º ÀΰÝÀå¾Ö
  • personality disorder, passive
    ¼öµ¿¼º(áôÔÑàõ) ÀΰÝÀå¾Ö
  • personality disorder, passive-aggressive
    ¼öµ¿°ø°Ý¼º ÀΰÝÀå¾Ö
  • personality disorder, psychopathic
    Á¤½Åº´Áú(ïñãêÜ»òõ)¼º ÀΰÝÀå¾Ö
  • personality disorder, schizoid
    ºÐ¿­¼º(ÝÂæñàõ) ÀΰÝÀå¾Ö
  • personality disorder, schizotypal
    ºÐ¿­Çü ÀΰÝÀå¾Ö
  • personality disorder, self- defeating
    ÀÚ±âÆÐ¹è¼º(í»Ðùø¨ÛÅàõ) ÀΰÝÀå¾Ö
  • personality disorder, sociopathic
    »çȸº´Áú¼º(ÞäüåÜ»òõàõ) ÀΰÝÀå¾Ö
  • pervasive developmental disorder
    Àü¹ÝÀû ¹ß´ÞÀå¾Ö(îïÚõîÜÛ¡Ó¹î¡äô)
  • phencyclidine use disorder
    Ææ½ÎÀÌŬ¸®µò »ç¿ëÀå¾Ö(º´)
  • phobic anxiety disorder
    °øÆ÷ºÒ¾ÈÀå¾Ö, ~º´
  • phobic disorder
    °øÆ÷Àå¾Ö,°øÆ÷º´
  • phonation disorder
    ¹ß¼ºÀå¾Ö
  • phonological disorder
    À½¼ºÇÐÀû Àå¾Ö, ~ º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • personality, type A
    AÇü ÀΰÝ
  • personality, type B
    BÇü ÀΰÝ
  • phage type
    ÆÄÁöÇü
  • phage type
    ÆÄÁöÇü(¡­úþ).
  • phased linear array type
    À§»óÂ÷ ¹è¿­½Ä ¼±Çü (êÈßÓó¬ ÛÕÖªãÒ àÊû¡) Æ®·£½ºµà¼­
  • phased linear array type
    À§»óÂ÷ ¼±Çü ¹è¿­½Ä
  • phthisic type
    ³ëÁõº¸Çü( ñøÜÁúþ).
  • phthisic type
    ³ëÁõº¸Çü(Ò¾ñøÜÁúþ)
  • pilus, type 1
    Á¦1Çü ¼¶¸ð
  • plaque-type mutation
    ÇöóÅ©Çü µ¹¿¬º¯ÀÌ
  • platelet-type
    Ç÷¼ÒÆÇÇü(û¡)
  • pneumocyte type i
    È£ÈíÇãÆÄ²Ê¸®¼¼Æ÷
  • pneumocyte type ii
    °ú¸³ÇãÆÄ²Ê¸®¼¼Æ÷
  • precision type attachment
    Á¤¹ÐÇü¾îÅÂÄ¡ ¸ÕÆ®.
  • propagative type
    Áõ½ÄÇü(Ì¡ËàÌ´).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
HID headache, insomnia, depression [syndrome]; herniated intervertebral disc; human infectious dose; hyp...
IAHD idiopathic acquired hemolytic disorder
ICD I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso...
IED inherited epidermal dysplasia; intermittent explosive disorder
LD labor and delivery; laboratory data; labyrinthine defect; lactate dehydrogenase; laser Doppler; lear...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 10
ODS Osteogenic Disorder Shionogi
PD Panic Disorder
PDA Panic Disorder with Agoraphobia
PLMD Periodic Limb Movement Disorder
PD Personality Disorder
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • inflammatory joint disorder
    ¿°Áõ¼º °üÀý Àå¾Ö
  • intermittent explosive disorder
    °£ÇæÀû Æø¹ß¼º Àå¾Ö
    °£ÇæÀûÀ¸·Î ¿©·¯ ¹ø °ø°Ý¼º Ãæµ¿ÀÇ Á¶Á¤À» »ó½ÇÇÏ¿© ±× »ç¶÷ÀÇ Á¤»óÀû Àΰݿ¡ ¸ÂÁö ¾Ê´Â ½ÉÇÑ ÆøÇàÀ̳ª ±â¹° ÆÄ±«¸¦ ÃÊ·¡ÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÎ ±â´ÉÀû Á¤½Å Àå¾ÖÀÇ ÀÏÁ¾. Àü¿¡´Â Æø¹ß¼º ÀÎ°Ý ¶Ç´Â °£ÁúÇü ÀÎ°Ý Àå¾Ö¶ó°í ĪÇߴµ¥, °£ÇæÀû ÇൿÀÌ ÀÎ°Ý Æ¯¼ºÀÌ µÉ ¼ö ¾øÀ¸¹Ç·Î À߸øµÈ ȣĪÀÌ´Ù.
  • intracapsular disorder
    °üÀý³¶³» Àå¾Ö
  • joint disorder
    °üÀý Àå¾Ö
  • language disorder
    ¾ð¾î Àå¾Ö
    ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇÏ°Ô ÀÌÇØÇÏÁö ¸øÇÏ´Â »óÅÂ. Àΰ£Àº ¸»
  • late luteal phase dysphoric disorder
    ¸»±â Ȳü±â ºÒÄè Àå¾Ö
  • major depressive disorder
    ÁÖ¿ä ¿ì¿ïÁõ
  • masticatory muscle pain disorder
    ÀúÀÛ±Ù µ¿Åë Àå¾Ö
  • menopausal disorder
    °»³â±â Àå¾Ö
    °»³â±â¿¡ »ý±â´Â ÀÚÀ²½Å°æ ½ÇÁ¶Áõ. ³­¼ÒÀÇ ³»ºÐºñ ±â´ÉÀÇ °¨Å𳪠ÆóÀýÀÌ ÁÖµÈ ¿øÀÎÀ̸ç, ¶ÇÇÑ °¢Á¾ÀÇ ³»ºÐºñ¼±, ƯÈ÷ ³úÇϼöü Àü¿±, °©»ó¼±, ºÎ½Å ¶Ç´Â ÃéÀå µîÀÇ ±â´ÉÀå¾Ö·Î ±×µé »óÈ£°£ÀÇ ÆòÇü ½ÇÁ¶¸¦ °¡Á®¿À°í, ³¡³»´Â ³»ºÐºñ Àå±â¸¦ Áö¹èÇÏ´Â ÀÚÀ²½Å°æ °èÅë¿¡ ¿µÇâÀ» ³¢ÃÄ ±³°¨½Å°æ ¶Ç´Â ºÎ±³°¨½Å°æ¿¡ ±äÀåÀ» ÃÊ·¡Çϱ⠶§¹®À̶ó°í ¿©°ÜÁö°í ÀÖ´Ù. Áõ¼¼¿¡´Â ±¹ºÎÀû Áõ¼¼¿Í Àü½Å Áõ¼¼°¡ ÀÖ´Ù. ±¹ºÎÀûÀÎ Áõ¼¼·Î´Â ³»¿Ü ¼º±âÀÇ À§ÃàÀÌ ÁÖµÈ Áõ»óÀÌ´Ù. ¿Ü¼º±âÀÎ ´ë, ¼ÒÀ½¼øÀº Áö¹æÀÇ ¼Ò½Ç·Î À§ÃàµÇ°í, À½¸ð´Â ¹«»öÀÌ µÈ´Ù. ³»¼º±â¿¡¼­´Â Áú º®ÀÌ ÆòÆòÇØÁö°í Áú °­Àº Á¼¾ÆÁö´Âµ¥, ¶§·Î´Â Áú¿° ¶§¹®¿¡ Áú °­ÀÌ À¯ÂøµÈ´Ù. ÀÚ±ÃÀº ±Ù¼¶À¯ÀÇ À§ÃàÀ¸·Î ÀüüÀûÀ¸·Î Âɱ׶óµé¸ç, °æ°ü ¹× ³» Àڱà ±¸´Â ¸Å¿ì Á¼¾ÆÁ®¼­ ¶§·Î´Â Æó¼âµÇ¾î À¯¼öÁ¾ ¶Ç´Â À¯³óÁ¾ÀÌ »ý±æ ¶§µµ ÀÖ´Ù. ³­¼Ò´Â ÀÛ¾ÆÁö°í ±â´Éµµ °¨ÅðÇÏ¿© ƯÀ¯ÀÇ ³­¼Ò ÁÖ±âÀÇ ºÒ±ÔĢȭ¿¡ µû¶ó ¿ù°æ ºÒ¼øÀ» ÀÏÀ¸Å°¸ç ¿ÏÀü Æó°æ¿¡ À̸¥´Ù. ³­°ü, Àڱà Àδë, º¹¸· µîµµ À§ÃàÇÑ´Ù. Á¦2Â÷ ¼ºÂ¡À¸·Î À¯¹æ°ú Àü½Å¿¡ °ÉÃÄ ÇÇÇÏ Áö¹æ Á¶Á÷ÀÇ ¼Ò½ÇÀÌ ÀϾ ¿©¼º´Ù¿î ¸ö¸Å¸¦ ÀÒ°Ô µÇ°í, ½ÉÁö¾î´Â ÀÔ°¡¿¡ ¼ö¿°ÀÌ ³ª´Â µî ³²¼ºÀûÀ¸·Î º¯¸ðÇÏ´Â °æ¿ìµµ ÀÖ´Ù. Àü½ÅÀÇ Áõ¼¼·Î´Â Ç÷°ü ¿îµ¿ ½Å°æ Àå¾Ö¿Í ÀÚÀ²½Å°æÁõÀÎ ¿­°¨, ³ÃÁõ, ÈïºÐ°¨, ½É°è Ç×Áø, ºÎÁ¤¸Æ, ºÎÁ¾ µîÀÌ ÀÖ´Ù. Á¤½Å ½Å°æ Àå¾Ö·Î´Â µÎÅë, µÎÁß°¨, Çö±âÁõ, ºÒ¸éÁõ, À̸íÁõ, ¿ì¿ïÁõ
  • metabolism disorder
    ´ë»ç Àå¾Ö
  • monopolar disorder
    ´Ü±Ø¼º Àå¾Ö
  • mood disorder
    ±âºÐ Àå¾Ö
  • motor output disorder
    ¿îµ¿¼º Ãâ·Â Àå¾Ö
  • motor skills disorder
    ¿îµ¿ ´É·Â Àå¾Ö
  • multisystem disorder
    ´Ù¹ßÀû Àü½Å ÀÌ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
glycogen storage disease type V <disease> Glycogenosis due to muscle phosphorylase deficiency. Characterised by painful cramps following sustained exercise.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type VI <disease> A hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity. However, studies have not been able to distinguish between phosphorylase deficiency and phosphorylase kinase deficiency in patients with hepatic glycogenosis.
(12 Dec 1998)
glycogen storage disease type VII <disease> An autosomal recessive muscle glycogen storage disease in which there is deficient expression of muscle phosphofructokinase activity, resulting in increased concentrations of glucose-6-phosphate and fructose-6-phosphate and low concentrations of fructose-1,6-diphosphate in muscle tissue.
Glycogen storage in muscle is increased, perhaps due to activation of glycogen synthase by accumulated glucose-6-phosphate. It has been proposed that shunting of glucose-6-phosphate and fructose-6-phosphate into the pentose phosphate pathway may result in increased synthesis of purines and pyrimidines, causing hyperuricaemia and gout.
Erythrocytes from patients may show decreased phosphofructokinase activity and 2,3-diphosphoglycerate deficiency. Exercise intolerance is present and severe congenital muscular dystrophy has been reported.
Inheritance: autosomal recessive
(12 Dec 1998)
glycogen storage disease type VIII <disease> An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon.
Inheritance: X-linked recessive
(12 Dec 1998)
V-type ATPase <enzyme> From eukaryotic endomembrane systems, including vacuoles, lysosomes, golgi apparatus, chromaffin granules and coated vesicles. One of three major classes of ion transport ATPase, characterised by a multi subunit structure and a lack of a phosphorylated intermediate.
Found in archaebacteria but not eubacteria, in the intracellular acidic vacuoles and in some proton pumping epithelia (e.g. Intercalated cells of kidney). A complex enzyme encoded by several genes, involved in ion translocation but does not act via phosphorylated enzyme intermediate
See: P-type ATPase.
Registry number: EC 3.6.1.-
Synonym: atpase, v-type, atpase, vacuolar, vacuolar atpase, v-atpase, vacuolar h+-atpase, vacuolar membrane h(+)-atpase, vha55 gene product, vma16 gene product
(26 Jun 1999)
Gm type <immunology> Genetically determined allotypic antigens found on IgG of some individuals.
(18 Nov 1997)
Golgi type II neuron <physiology> Nerve cells with short axons which ramify in the gray matter.
(05 Mar 2000)
Golgi type I neuron <physiology> Nerve cells whose long axons leave the gray matter of which they form a part.
(05 Mar 2000)
membrane-type 3 matrix metalloproteinase <enzyme> Sm3 is a soluble form of mt3-mmp, probably an alternatively sliced variant.
Registry number: EC 3.4.24.-
Synonym: mt3-mmp, sm3-mmp
(26 Jun 1999)
membrane-type 4 matrix metalloproteinase <enzyme> Cloned from breast carcinoma.
Registry number: EC 3.4.24.-
Synonym: mt4-mmp, mmp-17 gene product, mmp-17
(26 Jun 1999)
membrane-type matrix metalloproteinase <enzyme> Activates gelatinase a; isolated from a human placenta cdna gene library; contains a transmembrane domain; do not use for any other numbered matrix metalloproteinases; genbank d26512
Registry number: EC 3.4.24.-
Synonym: mt-mmp, mmp-x1 protein, matrix metalloproteinase, membrane-type, mmp14 gene product, mmp-14 gene product, mt1-mmp, matrix metalloproteinase 14, mt2-mmp, mmp15 gene product, mmp16 gene product
(26 Jun 1999)
retroviruses type b, mammalian A genus of the family retroviridae consisting of a few exogenous, vertically transmitted and endogenous viruses of mice. It is associated with mammary carcinoma and T-cell lymphoma.
(12 Dec 1998)
retroviruses type c, avian A genus of the family retroviridae with type c morphology, that causes malignant and other diseases in wild birds and domestic fowl.
(12 Dec 1998)
retroviruses type c, mammalian A genus of retroviridae comprising endogenous sequences in mammals, related reticuloendotheliosis viruses of birds, and a reptilian species. Many species contain oncogenes and cause leukaemias and sarcomas.
(12 Dec 1998)
retroviruses, type d A genus of the family retroviridae consisting of oncogenic exogenous retroviruses that contain type d particles. They include the type species, mason-pfiser monkey virus, isolated from mammary carcinoma and normal tissues in rhesus monkeys, and several other serotypes of simian type d retroviruses (retroviruses type d, simian), all of which cause simian aids (saids) and other malignancies. The permanent human fibroblast virus (pmfv) is also type d. The core of the type d viruses is the intracytoplasmic type a particle and its mechanism of budding from the cell membrane is similar to the type b oncoviruses.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 10
ÅëÇÕ°Ë»ö ¿Ï·á